Opus Genetics IRD
NASDAQ IRD
$4.58 +0.07 (+1.55%)
At close: Oct 2, 2026 · 4:00 PM EDT

Opus Genetics (IRD) Return on Sales [ROS] (2010 - 2026)

Updated

Opus Genetics' Return on Sales [ROS] came in at -2182.78% for Q2 2026, down 1873.76 percentage points from -309.02% a year earlier and down 1516.86 percentage points from the prior quarter.

Analysis

Opus Genetics (IRD) Return on Sales [ROS] (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Opus Genetics reported Return on Sales [ROS] of -513.47%, down 92.79 percentage points year-over-year; for FY2025, it came in at -271.90%, up 292.82 percentage points from FY2024.

  • Return on Sales [ROS] carries a four-year change of +3582.94 percentage points (FY2021 to FY2025).
  • Going back by year, Return on Sales [ROS] was -564.72% in FY2024 (-509.27 pp), -55.45% in FY2023 (-101.19 pp), 45.74% in FY2022 (+3900.58 pp) and -3854.84% in FY2021.
  • The Q2 2026 figure represents the lowest quarterly Return on Sales [ROS] since Q2 2022.
  • Year-over-year, Return on Sales [ROS] increased in three of the last eight quarters, with an average year-over-year change of -243.50 percentage points.
  • The fastest year-over-year change in Return on Sales [ROS] over five years came in Q2 2023 (a gain of 4317.12 percentage points), and the weakest in Q4 2021 (a drop of 2118.49 percentage points).
  • Business Quant data shows IRD's Return on Sales [ROS] at -665.92% (Q1 2026), -296.33% (Q4 2025) and -269.93% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Opus Genetics 378.53 Mn 153.81 Mn - -2,182.78%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,182.78%
Mar 31, 2026 -665.92%
Dec 31, 2025 -296.33%
Sep 30, 2025 -269.93%
Jun 30, 2025 -309.02%
Mar 31, 2025 -227.21%
Dec 31, 2024 -883.98%
Sep 30, 2024 -207.11%
Jun 30, 2024 -748.92%
Mar 31, 2024 -450.50%
Dec 31, 2023 -321.05%
Sep 30, 2023 53.51%
Jun 30, 2023 -146.68%
Mar 31, 2023 -350.54%
Dec 31, 2022 85.85%
Jun 30, 2022 -4,463.80%
Mar 31, 2022 -4,079.29%
Dec 31, 2021 -3,854.84%
Sep 30, 2021 -865.44%
Jun 30, 2021 -7,137.00%
API Access

Opus Genetics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IRD&period=max&api_key=YOUR_API_KEY